1-(2-Chlorobenzyl)-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 97.0%, 250mg

ELIPRODIL, 95%, 5mg

1-BOC-4-ETHYL-4-(HYDROXYMETHYL)-PIPERIDINE, 95.0%, 5g

Ethyl 4-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate, 95.0%, 1g

5-(tert-Butyl) 2-ethyl 4-oxo-7,8-dihydro-4H-pyrazolo[1,5-a][1,4]diazepine-2,5(6H)-dicarboxylate, 98%, 1g

(S)-2-Amino-2-(4-bromophenyl)acetic acid hydrochloride, 95.0%, 100mg

Flat flange reaction vial, cylindrical, graduated, with tempering jacket KF connecting piece, DN 100, 250 ml, 130 mm, 1 Piece

5-Amino-2-hydroxybenzoic acid, 97.00%, 1kg

3-(Pyrrolidino)phenylboronic acid, 95.0%, 5g

2-bromo-N-(4-ethoxyphenyl)acetamide, 250mg

4-(1,1,2,2,2-Pentafluoroethoxy)benzoic acid, 250mg

(R)-(+)-1-(4-Methoxyphenyl)ethylamine hydrochloride, 95.0%, 1g

(1-(Tetrahydro-2H-pyran-2-yl)-1H-pyrazol-4-yl)methanol, 95.0%, 250mg